AHRQ’s Evidence Report on Depression, CYP450 Testing for Adults Treated with SSRIs concluded “There is a paucity of good-quality data addressing the questions of whether testing for CYP450 polymorphisms in adults entering SSRI treatment for non-psychotic depression leads to improvement in outcomes, or whether testing results are useful in medical, personal, or public health decisionmaking.” [...]
Filed under: Cytochrome P450, Personalized Medicine, Pharmacogenetics | Tagged: DNA, Personalized Medicine, Pharmacogenetics | 1 Comment »
